HCPCS Level II › M
HCPCS Level II codes starting with M
506 codes, page 5 of 6. Every code ever valid for billing is listed, including those now retired.
| Code | Description | Status |
|---|---|---|
| M1398 | Patients with baseline and follow-up promis surveys documented in the medical record | Valid |
| M1399 | Patients who leave the practice during the follow-up period | Valid |
| M1400 | Patients who died during the follow-up period | Valid |
| M1401 | Stages i-iii breast cancer | Valid |
| M1402 | Patients receiving an initial chemotherapy regimen with a defined duration with the eligible clinician or group | Valid |
| M1403 | Patients with baseline and follow-up promis surveys documented in the medical record | Valid |
| M1404 | Patients on a therapeutic clinical trial | Valid |
| M1405 | Patients with recurrence/disease progression | Valid |
| M1406 | Patients who leave the practice during the follow-up period | Valid |
| M1407 | Patients who died during the follow-up period | Valid |
| M1408 | Patients who have germline brca testing completed before diagnosis of epithelial ovarian, fallopian tube, or primary peritoneal cancer | Valid |
| M1409 | Patients who received germline testing for brca1 and brca2 or genetic counseling completed within 6 months of diagnosis | Valid |
| M1410 | Patients who did not have germline testing for brca1 and brca2 or genetic counseling completed within 6 months of diagnosis | Valid |
| M1411 | Currently on first-line immune checkpoint inhibitors without chemotherapy | Valid |
| M1412 | Patients with metastatic nsclc with epidermal growth factor receptor (egfr) mutations, alk genomic tumor aberrations, or other targetable genomic abnormalities with approved first-line targeted therapy, such as nsclc with ros1 rearrangement, braf v600e mutation, ntrk 1/2/3 gene fusion, met ex14 skipping mutation, and ret rearrangement | Valid |
| M1413 | Patients who had a positive pd-l1 biomarker expression test result prior to the initiation of first-line immune checkpoint inhibitor therapy | Valid |
| M1414 | Documentation of medical reason(s) for not performing the pd-l1 biomarker expression test prior to initiation of first-line immune checkpoint inhibitor therapy (e.g., patient is in an urgent or emergent situation where delay of treatment would jeopardize the patient's health status; other medical reasons/contraindication) | Valid |
| M1415 | Patients who did not have a positive pd-l1 biomarker expression test result prior to the initiation of first-line immune checkpoint inhibitor therapy | Valid |
| M1416 | Patient received hospice services any time during the performance period | Valid |
| M1417 | Patients who are up to date on their covid-19 vaccinations as defined by cdc recommendations on current vaccination | Valid |
| M1418 | Patients who are not up to date on their covid-19 vaccinations as defined by cdc recommendations on current vaccination because of a medical contraindication documented by clinician | Valid |
| M1419 | Patients who are not up to date on their covid-19 vaccinations as defined by cdc recommendations on current vaccination | Valid |
| M1420 | Complete ophthalmologic care mips value pathway | Valid |
| M1421 | Dermatological care mips value pathway | Valid |
| M1422 | Gastroenterology care mips value pathway | Valid |
| M1423 | Optimal care for patients with urologic conditions mips value pathway | Valid |
| M1424 | Pulmonology care mips value pathway | Valid |
| M1425 | Surgical care mips value pathway | Valid |
| M1426 | Encounters conducted via telehealth | Valid |
| M1427 | Documentation of medical reason(s) for performing a bone scan (including documented pain related to prostate cancer, salvage therapy, other medical reasons) | Valid |
| M1428 | Patients who have bilateral absence of eyes any time during the patient's history through the end of the measurement period | Valid |
| M1429 | Retinal exam finding with evidence of retinopathy in left, right or both eyes with severity level documented | Valid |
| M1430 | Retinal exam finding without evidence of retinopathy in both eyes with severity level documented (in measurement year or in the prior year) | Valid |
| M1431 | Encounters conducted via telehealth | Valid |
| M1432 | Encounters conducted via telehealth | Valid |
| M1433 | Patient on oral chemotherapy on or within 30 days before denominator eligible encounter | Valid |
| M1434 | Patient on oral chemotherapy on or within 30 days after denominator eligible encounter | Valid |
| M1435 | Patient on oral chemotherapy during the performance period | Valid |
| M1436 | Encounters conducted via telehealth | Valid |
| M1437 | Encounters conducted via telehealth | Valid |
| M1438 | Time last known well to hospital arrival less than or equal to 3.5 hours (<= 210 minutes) | Valid |
| M1439 | Significant ocular conditions that impact the visual outcome of surgery | Valid |
| M1440 | Encounters conducted via telehealth | Valid |
| M1441 | Encounter corresponds to initial diagnosis of sleep apnea or first contact with sleep apnea diagnosed patient | Valid |
| M1442 | Encounters conducted via telehealth | Valid |
| M1443 | Encounters conducted via telehealth | Valid |
| M1444 | Delivery at < 39 weeks of gestation | Valid |
| M1445 | Postpartum care visit before or at 12 weeks of giving birth | Valid |
| M1446 | Patients who died any time prior to the end of the measure assessment period | Valid |
| M1447 | Patients with an active diagnosis of bipolar disorder any time prior to the end of the measure assessment period | Valid |
| M1448 | Patients with an active diagnosis of personality disorder any time prior to the end of the measure assessment period | Valid |
| M1449 | Patients with an active diagnosis of schizophrenia or psychotic disorder any time prior to the end of the measure assessment period | Valid |
| M1450 | Patients who received hospice or palliative care service any time during denominator identification period or the measure assessment period | Valid |
| M1451 | Patients with an active diagnosis of pervasive developmental disorder any time prior to the end of the measure assessment period | Valid |
| M1452 | Patient ever had a diagnosis of dementia | Valid |
| M1453 | Patients with a pre-operative visual acuity better than 20/40 | Valid |
| M1454 | New cied | Valid |
| M1455 | Replaced or revised cied | Valid |
| M1456 | Patient had a heart transplant | Valid |
| M1457 | Patient had a diagnosis of asthma with any contact during the current or prior performance period or had asthma present on an active problem list any time during the performance period | Valid |
| M1458 | Patient died prior to the end of the performance period | Valid |
| M1459 | Patient was in hospice or receiving palliative care services at any time during the performance period | Valid |
| M1460 | Diagnosis for chronic obstructive pulmonary disease, emphysema, cystic fibrosis, or acute respiratory failure | Valid |
| M1461 | Patient diagnosis for chronic hepatitis c | Valid |
| M1462 | Patients with clinical indications for imaging of the head | Valid |
| M1463 | Documentation of at least two attempts to follow up with patient within 180 days of treatment | Valid |
| M1464 | No documentation of at least two attempts to follow up with patient within 180 days of treatment | Valid |
| M1465 | Patient follow up more than 180 days after treatment | Valid |
| M1466 | Patient had a lumbar fusion on the same date as the discectomy/laminectomy procedure | Valid |
| M1467 | Patients with an existing diagnosis of lynch syndrome | Valid |
| M1468 | Patient received recommended doses of hepatitis b vaccination based on age | Valid |
| M1469 | Patient has a history of hepatitis b illness or received a hepatitis b surface antigen, hepatitis b surface antibody, or total antibody to hepatitis b core antigen test with a positive result any time before or during the measurement period | Valid |
| M1470 | Documentation of medical reason(s) for not administering hepatitis b vaccine (e.g., prior anaphylaxis due to the hepatitis b vaccine) | Valid |
| M1471 | Documentation that patient is a medicare fee-for-service beneficiary and without additional supplementary insurance coverage for whom hep b vaccination is not reimbursable under current medicare part b coverage rules | Valid |
| M1472 | Patient did not receive recommended doses of hepatitis b vaccination based on age | Valid |
| M1473 | Patient situations, at any point during the denominator identification period, where the patient's functional capacity or motivation (or lack thereof) to improve may impact the accuracy of results of validated tools, such as delirium, dementia, intellectual disabilities, and pervasive and specific development disorders | Valid |
| M1474 | Patients with diagnosis of dementia | Valid |
| M1475 | Patients with diagnosis of huntington's disease | Valid |
| M1476 | Patients with diagnosis of cognitive impairment or alzheimer's disease | Valid |
| M1477 | Diagnosis of delirium | Valid |
| M1478 | Psychoactive substance abuse | Valid |
| M1479 | Patients whose functional capacity or motivation (or lack thereof) to improve may impact the accuracy of results of validated tools such as delirium, dementia, intellectual disabilities, and pervasive and specific development disorders | Valid |
| M1480 | Patients whose functional capacity or motivation (or lack thereof) to improve may impact the accuracy of results of validated tools such as delirium, dementia, intellectual disabilities, and pervasive and specific development disorders | Valid |
| M1481 | Patients receiving hospice or palliative care or who died during the measurement period | Valid |
| M1482 | Positive/detectable hepatitis c virus quantitative or qualitative rna test result during the denominator identification period | Valid |
| M1483 | Patients who achieve sustained virological response as identified by an hcv rna test (cpt 87522) or (cpt 87521) with a negative/undetectable hcv rna result that occurred 20 weeks to 12 months after the first positive/detectable hcv rna test result within the denominator identification period | Valid |
| M1484 | Patients who did not have a repeat hcv rna labs performed for medical reasons documented by clinician (e.g., patient with limited life expectancy, delay in treatment of hcv related to treatment of hiv, hbv, hepatocellular carcinoma, decompensated cirrhosis) | Valid |
| M1485 | Patients who did not achieve sustained virological response as identified by an hcv rna test (cpt 87522) or (cpt 87521) with a negative/undetectable hcv rna result that occurred 20 weeks to 12 months after the first positive/detectable hcv rna test result within the denominator identification period | Valid |
| M1486 | Patients admitted to a skilled nursing facility (snf) during the period of evaluation | Valid |
| M1487 | Patients in hospice in the year before or during the period of evaluation | Valid |
| M1488 | Patients with a diagnosis for dementia in the year before or during the period of evaluation | Valid |
| M1489 | Patient status documented | Valid |
| M1490 | Patient status not documented | Valid |
| M1491 | Receiving esrd mcp dialysis services by the provider during the performance period | Valid |
| M1492 | Patients who did not report a fall | Valid |
| M1493 | Documentation of falls not performed due to medical reasons (e.g., syncope, vertigo and related disorders, restless leg syndrome, tourette syndrome/tic disorder, back pain, concussion/mild traumatic brain injury (mtbi), cervical dystonia, or epilepsy) | Valid |
| M1494 | Patients that reported a fall since the last visit | Valid |
| M1495 | Patients that reported a fall occurred who had a plan of care for falls documented or patients that did not report a fall | Valid |
| M1496 | Patients that had a fall who did not have a plan of care for falls documented or do not have documentation of being assessed for falls | Valid |
| M1497 | Documentation of falls not performed due to medical reasons (e.g., syncope, vertigo and related disorders, restless leg syndrome, tourette syndrome/tic disorder, back pain, concussion/mild traumatic brain injury (mtbi), cervical dystonia, or epilepsy) | Valid |